Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
UBS
McKesson
Colorcon
Dow
Mallinckrodt
Daiichi Sankyo
US Department of Justice
Johnson and Johnson

Generated: July 21, 2018

DrugPatentWatch Database Preview

OTIPRIO Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Otiprio, and what generic alternatives are available?

Otiprio is a drug marketed by Otonomy Inc and is included in one NDA. There are five patents protecting this drug.

This drug has one hundred and twenty-eight patent family members in nineteen countries.

The generic ingredient in OTIPRIO is ciprofloxacin. There are thirty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.
Summary for OTIPRIO
Drug patent expirations by year for OTIPRIO
Pharmacology for OTIPRIO
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Medical Subject Heading (MeSH) Categories for OTIPRIO
Synonyms for OTIPRIO
1-Cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-[1-piperazinyl)-quinoline-3-carboxylic Acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinoline-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline -3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1piperazinyl)-3quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride
3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-
3-Quinolinecarboxylic acid,1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)
3-Quinolinecarboxylicacid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
5E8K9I0O4U
721C331
85721-33-1
A-8526
AB0011928
AB1009412
AC-7613
AC1L1EEW
AJ-08409
AK163192
AKOS000269653
ALBB-015909
Alcon Cilox
AN-8829
ARONIS020379
AuriPro
AuriPro?
Bacquinor
Baflox
BAS 06989041
Bay 09867
Bay o 9867
Bay o 9867 (*Hydrochloride*)
BAY q 3939
Bay-09867
BAY-o 9867
BAY-Q-3939
Baycip
BAYQ3939
BBL005612
BC203729
BDBM21690
Bernoflox
Bi-Cipro
BIDD:GT0205
Bio-0540
BPBio1_000140
BRD-K04804440-311-02-3
BRN 3568352
BSPBio_000126
BSPBio_003344
C05349
C17H18FN3O3
CAS-93107-08-5
CBMicro_048498
CCG-39345
CCRIS 5241
Cetraxal
CHEBI:100241
CHEMBL8
Ciflox
Cifloxin
Cilab
Ciloxan
Ciloxan (*Hydrochloride*)
Ciplus
Ciprecu
Ciprine
Ciprinol
Cipro
Cipro (*Hydrochloride*)
Cipro (TN)
Cipro I.V.
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Cipro IV
Cipro XL
Cipro XR
Ciprobay
Ciprobay Uro
Ciprocinol
Ciprodar
Ciproflox
ciprofloxacillin
ciprofloxacin
Ciprofloxacin (Cipro)
Ciprofloxacin (JP17/USP/INN)
Ciprofloxacin [USAN:INN:BAN]
Ciprofloxacin [USAN:USP:INN:BAN]
Ciprofloxacin dihydrochloride
CIPROFLOXACIN EXTENDED RELEASE
Ciprofloxacin Hydrchloride
Ciprofloxacin In Dextrose 5%
Ciprofloxacin In Dextrose 5% In Plastic Container
Ciprofloxacin intratympanic - Otonomy
Ciprofloxacin monohydrochloride
Ciprofloxacin, >=98.0% (HPLC)
Ciprofloxacin, Antibiotic for Culture Media Use Only
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin, pharmaceutical secondary standard; traceable to USP and PhEur
Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard
Ciprofloxacin, VETRANAL(TM), analytical standard
Ciprofloxacina
Ciprofloxacine
Ciprofloxacine [INN-French]
Ciprofloxacino
Ciprofloxacino [INN-Spanish]
Ciprofloxacinum
Ciprofloxacinum [INN-Latin]
Ciprogis
Ciprolin
Ciprolon
Cipromycin
Ciproquinol
Ciprowin
Ciproxan
Ciproxin
Ciproxina
Ciproxine
Ciriax
Citopcin
Cixan
Corsacin
CPD000471901
CPF
CPFX
CS-2410
CTK3E8144
Cycin
Cyprobay
D00186
D03IHU
D0JW1A
DB00537
DivK1c_000095
DR001566
DTXSID8022824
Eni
Fimoflox
Flociprin
FT-0601635
HE397506
HMS1922E18
HMS2090O07
HMS2093I03
HMS500E17
HSDB 6987
HY-B0356
IDI1_000095
Ipiflox
Italnik
J10137
KB-117181
KB-152640
KBio1_000095
KBio2_000642
KBio2_003210
KBio2_005778
KBio3_002846
KBioGR_001567
KBioSS_000642
KS-000002BQ
KS-00004C43
KS-5006
Linhaliq
Linhaliq [Liposomal Formulation]
Loxan
LS-141563
MCULE-8631780654
MFCD00185755
MLS001336035
MLS006011837
MolPort-000-819-654
MYSWGUAQZAJSOK-UHFFFAOYSA-N
NCGC00016959-01
NCGC00016959-02
NCGC00016959-03
NCGC00016959-04
NCGC00016959-05
NCGC00016959-07
NCGC00095058-01
NCGC00095058-02
NCGC00178128-01
NINDS_000095
NSC-758467
NSC620634
NSC758467
Oprea1_008239
Oprea1_313572
OTO-201
Pharmakon1600-01503614
Prestwick0_000113
Prestwick1_000113
Prestwick2_000113
Prestwick3_000113
Probiox
Proflaxin
Proksi 250
Proksi 500
Quinolid
Quintor
Rancif
Roxytal
s2027
SAM002264604
SBB012554
SBI-0048462.P003
SC-17889
SCHEMBL2900
Septicide
SMP1_000125
SMR000471901
Sophixin Ofteno
SPBio_001474
SPBio_002065
Spectrum_000162
SPECTRUM1503614
Spectrum2_001567
Spectrum3_001872
Spectrum4_000874
Spectrum5_001089
Spitacin
SR-05000001863
SR-05000001863-3
ST024751
ST24046329
STK021082
Superocin
TX-017484
Unex
UNII-5E8K9I0O4U
Velmonit
Velomonit
Z56933707
ZINC20220
Zumaflox

US Patents and Regulatory Information for OTIPRIO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otonomy Inc OTIPRIO ciprofloxacin INJECTABLE, SUSPENSION;OTIC 207986-001 Dec 10, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Otonomy Inc OTIPRIO ciprofloxacin INJECTABLE, SUSPENSION;OTIC 207986-001 Dec 10, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Otonomy Inc OTIPRIO ciprofloxacin INJECTABLE, SUSPENSION;OTIC 207986-001 Dec 10, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Otonomy Inc OTIPRIO ciprofloxacin INJECTABLE, SUSPENSION;OTIC 207986-001 Dec 10, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for OTIPRIO

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,828,980 Controlled release corticosteroid compositions and methods for the treatment of otic disorders ➤ Sign Up
9,744,126 Controlled release corticosteroid compositions and methods for the treatment of otic disorders ➤ Sign Up
8,546,363 Controlled release corticosteroid compositions and methods for the treatment of otic disorders ➤ Sign Up
8,575,122 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for OTIPRIO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB12/058 United Kingdom ➤ Sign Up PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
C0012 France ➤ Sign Up PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
Mallinckrodt
Merck
Dow
Moodys
Chinese Patent Office
Citi
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.